These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6679253)

  • 1. [Use of monitoring theophylline in therapeutic indications of chronic bronchopneumopathies].
    Marzo C; Maselli R
    Arch Monaldi; 1983; 38(4):141-56. PubMed ID: 6679253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-functional study of the activity of a new xanthine derivative: bamifylline].
    Finiguerra M; Morandini GC
    Clin Ter; 1986 Jul; 118(2):125-35. PubMed ID: 3527540
    [No Abstract]   [Full Text] [Related]  

  • 3. The bronchodilator action of theophylline aerosol in subjects with chronic airflow obstruction.
    Bohadana AB; Peslin R; Teculescu D; Polu JM; Belleville F; Massin N
    Bull Eur Physiopathol Respir; 1980; 16(1):13-24. PubMed ID: 7357122
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhalational steroids in chronic obstructive bronchopneumonia].
    Urso DL; Luchetti L
    Recenti Prog Med; 2005 Dec; 96(12):611. PubMed ID: 16496747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atrial natriuretic factor (ANF) and chronic obstructive bronchopneumonia (COBP): the effects of theophylline treatment].
    Bartolucci L; Fioretti M; Rossi G; Commissari R; Valori C
    Clin Ter; 1996 Apr; 147(4):173-9. PubMed ID: 8766349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monitoring of medication in optimalization of preoral theophylline in long-term care].
    Schäfer K; Iwainsky H; Schilling W
    Pharmazie; 1986 Aug; 41(8):591-3. PubMed ID: 3097681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe and effective use of sustained-release and intravenous theophylline.
    Boggs PB
    Compr Ther; 1982 Mar; 8(3):17-21. PubMed ID: 7067393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J; Perré R
    Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the isotonic solution of theophylline for intravenous injection].
    Chazan R; Martusewicz M; Grubek-Jaworska H; Tymińska K; Droszcz W
    Pol Merkur Lekarski; 1996 Nov; 1(5):340-3. PubMed ID: 9273213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
    Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
    Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of sustained release theophylline preparations in chronic bronchospastic diseases].
    Nir I
    Harefuah; 1984 Mar; 106(5):235-6. PubMed ID: 6724423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum theophylline steady-state levels: comparative study of 2 retard preparations].
    Kaukel E; Koppermann G
    Prax Klin Pneumol; 1983 Mar; 37(3):109-12. PubMed ID: 6856560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.